Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in ...

Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and ...

Hypertension (high blood pressure) increases the risk of cardiovascular disease and mortality. Learn how damage from ...

A recent study has found a possible link between a commonly prescribed high blood pressure drug and an increased risk of ...

A study suggests that B vitamins could be an effective way to lower blood pressure, especially for people who do not respond ...

Scientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.

Mineralys Therapeutics said on Monday its lead drug significantly lowered blood pressure in patients with difficult-to-treat hypertension in late- and mid-stage trials.

Discover 7 tips to lower high blood pressure naturally, from the DASH diet to stress management techniques that can help you ...

The hypertension drug rilmenidine has been shown to slow down aging in worms, an effect that in humans could hypothetically ...

Topline data were announced from a trial investigating lorundrostat for the treatment of uncontrolled hypertension or resistant hypertension.

Discover how controlling hypertension serves as a powerful shield for kidney function and the steps you can take to protect ...

The development is set to make India less reliant on China for imports of raw material used by the pharmaceutical industry.